Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Genome-wide association is a promising approach to identify common genetic variants that predispose to human disease. Because of the high cost of genotyping hundreds of thousands of markers on thousands of subjects, genome-wide association studies often follow a staged design in which a proportion (pi(samples)) of the available samples are genotyped on a large number of markers in stage 1, and a proportion (pi(samples)) of these markers are later followed up by genotyping them on the remaining samples in stage 2. The standard strategy for analyzing such two-stage data is to view stage 2 as a replication study and focus on findings that reach statistical significance when stage 2 data are considered alone. We demonstrate that the alternative strategy of jointly analyzing the data from both stages almost always results in increased power to detect genetic association, despite the need to use more stringent significance levels, even when effect sizes differ between the two stages. We recommend joint analysis for all two-stage genome-wide association studies, especially when a relatively large proportion of the samples are genotyped in stage 1 (pi(samples) >or= 0.30), and a relatively large proportion of markers are selected for follow-up in stage 2 (pi(markers) >or= 0.01).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Joint analyses provide more statistical power than the power that meta-analysis approaches (Skol, et al., 2006)”
From A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin (2016) · cites this paper as Skol, et al., 2006
In the citing paper
“Post-hoc power analysis was performed for odds ratios ranging from 1.05 to 1.30 and across allele frequencies using CaTS61 with the estimated effective sample size.”
From Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) · cites this paper as [61]
In the citing paper
“Using equations from Wray et al. 2010 and our current heritability estimates, the 88 variant PRS explained a minimum 16% of the genetic liability of PD assuming a global prevalence of 0.5% (2,31).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
In the citing paper
“In a high-risk population with a prevalence of 2%, the 1805 variant PRS explained a maximum 36% of PD heritable risk (2,31) (Table S4).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
In the citing paper
“maximum potential AUC estimated at 85% using the equations from Wray et al. 2010”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
Citations
Cites
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Self-citationThe Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355 · cited 1×
“Note that equation (1) allows evidence for association to be combined without assuming equal effect sizes and allele frequencies for the two stages.”
BackgroundComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
The International SNP Map Working Group, Laboratories:, C. S. H., Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., National Center for Biotechnology Information:, Marth, G., Sherry, S., et al. (2001) · Nature · doi:10.1038/35057149 · Cited by 2,977 · cited 1×
“, enabled by rapidly decreasing genotyping costs, massively multiplexed genotyping technologies and the large-scale SNP discovery and genotyping efforts of the SNP Consortiu”
BackgroundGenome-wide association studies for common diseases and complex traits
Hirschhorn, J. N., & Daly, M. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1521 · Cited by 2,863 · cited 1×
“The false positive rate corresponding to thresholds C1 and Cjoint is amarker 1⁄4 P(|z1| 4 C1 AND |zjoint| 4 Cjoint) 1⁄4 P(|z1| 4 C1) P(|zjoint| 4 Cjoint | |z1| 4 C1), which can be calculated numerically by evaluating a simple integral (see equation (2) below).”
BackgroundProspects for whole-genome linkage disequilibrium mapping of common disease genes
Kruglyak, L. (1999) · Nature Genetics · doi:10.1038/9642 · Cited by 1,416
Association study designs for complex diseases
Cardon, L. R., & Bell, J. I. (2001) · Nature Reviews Genetics · doi:10.1038/35052543 · Cited by 1,395
Haplotype tagging for the identification of common disease genes
Johnson, G. C. L., Esposito, L., Barratt, B. J., Smith, A. N., Heward, J., Di Genova, G., Ueda, H., Cordell, H. J., Eaves, I. A., Dudbridge, F., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-233 · Cited by 1,174
Whole-Genome Patterns of Common DNA Variation in Three Human Populations
Hinds, D. A., Stuve, L. L., Nilsen, G. B., Halperin, E., Eskin, E., Ballinger, D. G., Frazer, K. A., & Cox, D. R. (2005) · Science · doi:10.1126/science.1105436 · Cited by 1,170
Genomic Control, a New Approach to Genetic-Based Association Studies
Devlin, B., Roeder, K., & Wasserman, L. (2001) · Theoretical Population Biology · doi:10.1006/tpbi.2001.1542 · Cited by 516
Cited by
Items 101–200 of 1,000
High Trans-ethnic Replicability of GWAS Results Implies Common Causal Variants
Marigorta, U. M., & Navarro, A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003566 · Cited by 209
“edu/csg/abecasis/CaTS/) [42].”
Xu, F.-H., Xiong, D., Xu, Y.-F., Cao, S.-M., Xue, W.-Q., Qin, H.-D., Liu, W.-S., Cao, J.-Y., Zhang, Y., Feng, Q.-S., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs320 · Cited by 209
“To increase the power of detecting the association (46) between EBV serostatus and smoking, we jointly analyzed the data from the three study populations after finding no heterogeneity between the Guangdong (21-RCCP and Sihui population) high-risk populations and the low-risk Yangquan population (Pheterogeneity = .”
MethodGenetics of autistic disorders: review and clinical implications
Freitag, C. M., Staal, W., Klauck, S. M., Duketis, E., & Waltes, R. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0076-x · Cited by 208
“Performing a GWA study in a sufficiently large sample and replicating the most significant SNPs in an independent sample with sufficient power is currently considered as a design avoiding the report of false positive findings [70].”
Chen, D. T., Jiang, X., Akula, N., Shugart, Y. Y., Wendland, J. R., Steele, C. J. M., Kassem, L., Park, J.-H., Chatterjee, N., Jamain, S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.157 · Cited by 208
Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis
Mayes, M. D., Bossini-Castillo, L., Gorlova, O., Martin, J. E., Zhou, X., Chen, W. V., Assassi, S., Ying, J., Tan, F. K., Arnett, F. C., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.12.002 · Cited by 208
“Power calculations were performed as implemented in Power Calculator for Genome-wide Analyses.(30)”
MethodMethods for Handling Multiple Testing
Rice, T. K., Schork, N. J., & Rao, D. C. (2008) · Advances in Genetics · doi:10.1016/s0065-2660(07)00412-9 · Cited by 206
Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis
Meulenbelt, I., Min, J. L., Bos, S., Riyazi, N., Houwing-Duistermaat, J. J., van der Wijk, H.-J., Kroon, H. M., Nakajima, M., Ikegawa, S., Uitterlinden, A. G., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn082 · Cited by 206
“05/the number of markers tested in the replication studies (19).”
BackgroundAssociation of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants
Nan, H., Hutter, C. M., Lin, Y., Jacobs, E. J., Ulrich, C. M., White, E., Baron, J. A., Berndt, S. I., Brenner, H., Butterbach, K., et al. (2015) · JAMA · doi:10.1001/jama.2015.1815 · Cited by 204
Increasing the power of identifying gene × gene interactions in genome‐wide association studies
Kooperberg, C., & LeBlanc, M. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20300 · Cited by 203
“Initially two-stage strategies were proposed as study designs to reduce the expense of a GWA, without a substantial reduction in the power to identify the (marginal) effect of SNPs on a disease [e.g. Lin, 2006; Skol et al., 2006, 2007; Thomas et al., 2004].”
BackgroundPopulation Substructure and Control Selection in Genome-Wide Association Studies
Yu, K., Wang, Z., Li, Q., Wacholder, S., Hunter, D. J., Hoover, R. N., Chanock, S., & Thomas, G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002551 · Cited by 200
“In a multiple-stage association study [30], the number of SNPs to be taken into the follow-up steps is usually fixed in advance by cost considerations so that the SNPs are selected based on the ranking of their test statistics rather than their P-values.”
BackgroundA genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release
Matarín, M., Brown, W. M., Scholz, S., Simón-Sánchez, J., Fung, H.-C., Hernandez, D., Gibbs, J. R., De Vrieze, F. W., Crews, C., Britton, A., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70081-9 · Cited by 196
A genome-wide association study of sporadic ALS in a homogenous Irish population
Cronin, S., Berger, S., Ding, J., Schymick, J. C., Washecka, N., Hernandez, D. G., Greenway, M. J., Bradley, D. G., Traynor, B. J., & Hardiman, O. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm361 · Cited by 195
“Even with the combined set of nearly 1000 cases and 1000 controls, the power to detect a SNP with an odds ratio of 1.5 is only 76% (based on a SNP with MAF of 0.26 and 300 000 markers) ( 34 ).”
BackgroundInfluentialBaune, B. T., Dannlowski, U., Domschke, K., Janssen, D. G. A., Jordan, M. A., Ohrmann, P., Bauer, J., Biros, E., Arolt, V., Kugel, H., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.004 · Cited by 193
Winkelmann, J., Czamara, D., Schormair, B., Knauf, F., Schulte, E. C., Trenkwalder, C., Dauvilliers, Y., Polo, O., Högl, B., Berger, K., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002171 · Cited by 193
“Power calculation Power calculation was performed using the CaTS power calculator [25] using a prevalence set of 0.”
MethodQuantifying and correcting for the winner's curse in genetic association studies
Xiao, R., & Boehnke, M. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20398 · Cited by 192
“C1 is calculated so that PðjZ1j4C1Þ ¼ pmarker, where pmarker is the propor- tion of markers to be genotyped in stage 2, and C12 by finding the threshold so that PðjZ1j4C1; jZ12j4C12Þ ¼ PðjZ12j4C12jjZ1j4C1Þ PðjZ1j4C1Þ results in the desired significance level [Skol et al., 2006].”
BackgroundMethodInfluentialSelf-citationFramingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes
Larson, M. G., Atwood, L. D., Benjamin, E. J., Cupples, L. A., D'Agostino, R. B., Fox, C. S., Govindaraju, D. R., Guo, C.-Y., Heard-Costa, N. L., Hwang, S.-J., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s5 · Cited by 190
“Two-stage approaches – genome-wide association followed by selective genotyping – have been adopted as a practical and efficient strategy for pursuing initial genome-wide results [25,26].”
MethodGROUP investigators, Børglum, A. D., Demontis, D., Grove, J., Pallesen, J., Hollegaard, M. V., Pedersen, C. B., Hedemand, A., Mattheisen, M., Uitterlinden, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.2 · Cited by 186
Landers, J. E., Melki, J., Meininger, V., Glass, J. D., van den Berg, L. H., van Es, M. A., Sapp, P. C., van Vught, P. W. J., McKenna-Yasek, D. M., Blauw, H. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812937106 · Cited by 185
“This approach is more powerful than a 2-staged method in which a set of SNPs within an initial population below a cutoff P value is verified within a secondary confirmation population (36).”
MethodGenome-Wide Association Studies and Beyond
Witte, J. S. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103723 · Cited by 167
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies
Erhardt, A., Czibere, L., Roeske, D., Lucae, S., Unschuld, P. G., Ripke, S., Specht, M., Kohli, M. A., Kloiber, S., Ising, M., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.41 · Cited by 182
Genetic variants and normal tissue toxicity after radiotherapy: A systematic review
Andreassen, C. N., & Alsner, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.015 · Cited by 181
“edu/csg/abecasis/ cats), which is based on calculations designed for both 1-stage and 2-stage designs [65].”
MethodDesigning candidate gene and genome-wide case–control association studies
Zondervan, K. T., & Cardon, L. R. (2007) · Nature Protocols · doi:10.1038/nprot.2007.366 · Cited by 178
“Subsequent analysis needs to be carried out for the different stages combined to maintain power leve”
BackgroundA second major histocompatibility complex susceptibility locus for multiple sclerosis
Yeo, T. W., De Jager, P. L., Gregory, S. G., Barcellos, L. F., Walton, A., Goris, A., Fenoglio, C., Ban, M., Taylor, C. J., Goodman, R. S., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21063 · Cited by 175
“Given that the US trio families provided independent evidence implicating the HLA-C region, we analyzed these new data from additional UK samples together with those from the 480 UK index cases used in the first screening experiment in the form of an extension analysis as opposed to a replication study.(50) Results fr…”
MethodCarmona, F. D., Mackie, S. L., Martín, J.-E., Taylor, J. C., Vaglio, A., Eyre, S., Bossini-Castillo, L., Castañeda, S., Cid, M. C., Hernández-Rodríguez, J., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.02.009 · Cited by 176
Byun, E., Caillier, S. J., Montalban, X., Villoslada, P., Fernández, O., Brassat, D., Comabella, M., Wang, J., Barcellos, L. F., Baranzini, S. E., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2008.47 · Cited by 174
Patin, E., Kutalik, Z., Guergnon, J., Bibert, S., Nalpas, B., Jouanguy, E., Munteanu, M., Bousquet, L., Argiro, L., Halfon, P., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.097 · Cited by 175
Swaroop, A., Branham, K. E., Chen, W., & Abecasis, G. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm212 · Cited by 173
“Although larger sample sizes will always provide more power and improve the chance of new discoveries, one cost-effective option is to use a few large case-control cohorts for initial screening of 100 000s of variants, followed by detailed examination of the positive genomic regions in additional cohorts (109).”
BackgroundSelf-citationBlood Pressure Loci Identified with a Gene-Centric Array
Johnson, T., Gaunt, T. R., Newhouse, S. J., Padmanabhan, S., Tomaszewski, M., Kumari, M., Morris, R. W., Tzoulaki, I., O'Brien, E. T., Poulter, N. R., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.10.013 · Cited by 167
“56 3 10 7 threshold as for our discovery analysis because testing the ten SNPs in combined analysis is slightly conservative compared to analyzing all SNPs for association in the full discovery plus follow-up sample size.(32,33)”
MethodSelf-citationTakeuchi, M., Mizuki, N., Meguro, A., Ombrello, M. J., Kirino, Y., Satorius, C., Le, J., Blake, M., Erer, B., Kawagoe, T., et al. (2017) · Nature Genetics · doi:10.1038/ng.3786 · Cited by 166
Lu, Y., Kweon, S.-S., Tanikawa, C., Jia, W.-H., Xiang, Y.-B., Cai, Q., Zeng, C., Schmit, S. L., Shin, A., Matsuo, K., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.066 · Cited by 165
Bandelow, B., Baldwin, D., Abelli, M., Altamura, C., Dell’Osso, B., Domschke, K., Fineberg, N. A., Grünblatt, E., Jarema, M., Maron, E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1181783 · Cited by 164
“A newly developed method, joint analysis could result in increased power to detect genetic association (Skol et al. 2006).”
MethodCurrent status of genome-wide association studies in cancer
Chung, C. C., & Chanock, S. J. (2011) · Human Genetics · doi:10.1007/s00439-011-1030-9 · Cited by 164
“Some have advocated that the combined P value across studies in different stages provides an important benchmark for the observation (Skol et al. 2006).”
BackgroundGenome-wide association study of coronary artery disease in the Japanese
Takeuchi, F., Yokota, M., Yamamoto, K., Nakashima, E., Katsuya, T., Asano, H., Isono, M., Nabika, T., Sugiyama, T., Fujioka, A., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.184 · Cited by 163
Sung, Y. J., Winkler, T. W., de las Fuentes, L., Bentley, A. R., Brown, M. R., Kraja, A. T., Schwander, K., Ntalla, I., Guo, X., Franceschini, N., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.015 · Cited by 163
Association mapping in plants in the post-GWAS genomics era
Gupta, P. K., Kulwal, P. L., & Jaiswal, V. (2019) · Advances in Genetics · doi:10.1016/bs.adgen.2018.12.001 · Cited by 162
The validity of circulating microRNAs in oncology: Five years of challenges and contradictions
Jarry, J., Schadendorf, D., Greenwood, C., Spatz, A., & van Kempen, L. C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.009 · Cited by 162
“If obtaining a large enough validation study is difficult, another approach to obtaining more accurate estimates of the true difference in expression is to perform metaanalyses of the magnitude of the expression differences across several independent studies (Ioannidis et al., 2001; Skol et al., 2006).”
Genetics of Venous Thrombosis: Insights from a New Genome Wide Association Study
Germain, M., Saut, N., Greliche, N., Dina, C., Lambert, J.-C., Perret, C., Cohen, W., Oudot-Mellakh, T., Antoni, G., Alessi, M.-C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025581 · Cited by 155
“20 [32].”
Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies
Zhong, H., & Prentice, R. L. (2008) · Biostatistics · doi:10.1093/biostatistics/kxn001 · Cited by 161
Salloum, R., Franek, B. S., Kariuki, S. N., Rhee, L., Mikolaitis, R. A., Jolly, M., Utset, T. O., & Niewold, T. B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27182 · Cited by 159
ICD-9 tobacco use codes are effective identifiers of smoking status
Wiley, L. K., Shah, A., Xu, H., & Bush, W. S. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-001557 · Cited by 152
HEIT, J. A., ARMASU, S. M., ASMANN, Y. W., CUNNINGHAM, J. M., MATSUMOTO, M. E., PETTERSON, T. M., & DE ANDRADE, M. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04810.x · Cited by 156
Qi, L., Qi, Q., Prudente, S., Mendonca, C., Andreozzi, F., di Pietro, N., Sturma, M., Novelli, V., Mannino, G. C., Formoso, G., et al. (2013) · JAMA · doi:10.1001/jama.2013.276305 · Cited by 153
“Current 109 (31) 264 (27) 32 (10) 80 (12) 32 (8) 22 (5) 53 (17) 62 (16) 17 (15) 33 (15)”
Fachal, L., Gómez‐Caamaño, A., Barnett, G. C., Peleteiro, P., Carballo, A. M., Calvo, P., Kerns, S. L., Sánchez-García, M., Lobato-Busto, R., Dorling, L., et al. (2014) · Nature Genetics · doi:10.1038/ng.3020 · Cited by 156
Pearson, J. V., Huentelman, M. J., Halperin, R. F., Tembe, W., Melquist, S., Homer, N., Brun, M., Szelinger, S., Coon, K. D., Zismann, V., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/510686 · Cited by 165
Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour
Peden, J. F., & Farrall, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr384 · Cited by 167
“(16) pointed out that a combined analysis of stage 1 discovery data (based on GWAS SNP arrays) and stage 2 validation data (a subset of the most promising SNPs from stage 1) is more efficient than attempting formal replication in stage 2 and such an analysis is now standard practise.”
BackgroundEPICURE Consortium, EMINet Consortium, Steffens, M., Leu, C., Ruppert, A.-K., Zara, F., Striano, P., Robbiano, A., Capovilla, G., Tinuper, P., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds373 · Cited by 153
“With respect to the relative low power of the Stage-2 replication cohorts, association analysis was based on joint Stage-1 and 2 analysis, which almost always has a superior power compared with Stage-2 analysis alone as replication study for Stage-1 association (62).”
MethodZhao, B., Zhang, J., Ibrahim, J. G., Luo, T., Santelli, R. C., Li, Y., Li, T., Shan, Y., Zhu, Z., Zhou, F., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0569-z · Cited by 151
A network of dopaminergic gene variations implicated as risk factors for schizophrenia
Talkowski, M. E., Kirov, G., Bamne, M., Georgieva, L., Torres, G., Mansour, H., Chowdari, K. V., Milanova, V., Wood, J., McClain, L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm347 · Cited by 146
“(25) recently showed that an increase in power for multi-stage whole-genome studies can be attained by evaluating the joint distribution of test statistics from both samples versus independent consideration of each sample.”
BackgroundVariants in the FTO gene are associated with common obesity in the Belgian population
Peeters, A. V., Beckers, S., Verrijken, A., Roevens, P. W. M., Peeters, P. J., Gaal, L. V., & Hul, W. V. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.10.011 · Cited by 156
Takeuchi, F., Isono, M., Nabika, T., Katsuya, T., Sugiyama, T., Yamaguchi, S., Kobayashi, S., Ogihara, T., Yamori, Y., Fujioka, A., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0774 · Cited by 146
Li, D., Lewinger, J. P., Gauderman, W. J., Murcray, C. E., & Conti, D. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20628 · Cited by 143
“The first strategy is similar in spirit to the joint analysis in the traditional two-stage design [Skol et al., 2006], in which the test statistics in the two stages are combined to produce a joint test statistic.”
MethodLeveraging Genetic Variability across Populations for the Identification of Causal Variants
Zaitlen, N., Paşaniuc, B., Gur, T., Ziv, E., & Halperin, E. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.11.016 · Cited by 164
“Under the null hypothesis (the allele frequencies in the cases and the controls are the same), this statistic is known to be distributed according to a standard normal distribution.(8) The alternative hypothesis is composite, depending on which SNP is causal and its relative risk.”
BackgroundPower, false discovery rate and Winner’s Curse in eQTL studies
Huang, Q. Q., Ritchie, S. C., Brozynska, M., & Inouye, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky780 · Cited by 141
“As with other studies (31,32) evaluating key genome-wide study design questions, large-scale simulation, where the true causal variant(s) and their effect(s) are known from the outset, is a critical tool for quantifying the relative performance of different approaches in diverse settings.”
Pirola, C. J., Garaycoechea, M., Flichman, D., Arrese, M., San Martino, J., Gazzi, C., Castaño, G. O., & Sookoian, S. (2019) · Journal of Lipid Research · doi:10.1194/jlr.p089953 · Cited by 142
“Using the CaTS power calculator for genetic association studies (17) and assuming a prevalence of NAFLD of 0.”
MethodCommon NOS1AP Variants Are Associated With a Prolonged QTc Interval in the Rotterdam Study
Aarnoudse, A. L. H. J., Newton‐Cheh, C., de Bakker, P. I. W., Straus, S. M. J. M., Kors, J. A., Albert Hofman, D., Uitterlinden, A. G., Witteman, J. C. M., & Stricker, B. H. C. (2007) · Circulation · doi:10.1161/circulationaha.106.676783 · Cited by 159
Genetic Analysis of Adult-Onset Autoimmune Diabetes
Howson, J. M. M., Rosinger, S., Smyth, D. J., Boehm, B. O., the ADBW-END Study Group, & Todd, J. A. (2011) · Diabetes · doi:10.2337/db11-0364 · Cited by 143
“Power calculations for association were performed using CaTS (24).”
MethodJanse, M., Lamberts, L. E., Franke, L., Raychaudhuri, S., Ellinghaus, E., Boberg, K. M., Melum, E., Folseraas, T., Schrumpf, E., Bergquist, A., et al. (2011) · Hepatology · doi:10.1002/hep.24307 · Cited by 138
“The combined analysis of the TaqMan genotyped data and the GWAS data was conducted using weighted Z-scores.(31) To take account of unequal numbers of cases and controls in the study panels, the effective sample size was used for the weighting of the Z-scores.”
MethodA second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility
Kanetsky, P. A., Mitra, N., Vardhanabhuti, S., Vaughn, D. J., Li, M., Ciosek, S. L., Letrero, R., D'Andrea, K. P., Vaddi, M., Doody, D. R., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr207 · Cited by 152
“26 (41), which is greater than those observed at these loci in our study.”
BackgroundO'Donnell, C. J., Cupples, L. A., D'Agostino, R. B., Fox, C. S., Hoffmann, U., Hwang, S.-J., Ingellson, E., Liu, C., Murabito, J. M., Polak, J. F., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s4 · Cited by 139
“In light of the multiple association tests that result from a GWAS, a powerful and efficient follow-up approach to increase the statistical confidence for an association of common variants with complex traits is a staged design, in which a modest number of results from the first stage are then tested in a second indep…”
D.E.S.I.R. Study Group, Albrechtsen, A., the DIAGRAM Consortium, Grarup, N., Li, Y., Sparsø, T., Tian, G., Cao, H., Jiang, T., Kim, S. Y., et al. (2013) · Diabetologia · doi:10.1007/s00125-012-2756-1 · Cited by 139
“To achieve sufficient statistical power a large number of the SNPs selected from stage 1 were genotyped in the much larger sample size in stage 2 making the statistical power comparable to a study where all individuals from both stage 1 and 2 are genotyped for all SNPs [19].”
BackgroundEstimating effects and making predictions from genome-wide marker dataPreprint
Goddard, M. E., Wray, N. R., VERBYLA, K. L., & Visscher, P. M. (2009) · Cited by 138
Tansey, K. E., Guipponi, M., Perroud, N., Bondolfi, G., Domenici, E., Evans, D., Hall, S. K., Hauser, J., Henigsberg, N., Hu, X., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001326 · Cited by 131
“The whole sample was analyzed jointly since this is a more efficient and powerful approach than discovery–replication design [29,30].”
MethodCensored rank independence screening for high-dimensional survival data
Song, R., Lu, W., Ma, S., & Jeng, X. J. (2014) · Biometrika · doi:10.1093/biomet/asu047 · Cited by 136
“The prefixed number may reflect researchers’ prior knowledge of the number of susceptible predictors, or budget limitations (Kuo & Zaykin, 2011; Skol et al., 2006).”
BackgroundFu, Y., Hallman, D. M., González, V. H., Klein, R., Klein, R., Hayes, M. G., Cox, N. J., Bell, G. I., & Hanis, C. L. (2010) · Journal of Ophthalmology · doi:10.1155/2010/861291 · Cited by 133
“…103 cases and 183 controls was only powerful enough to identify variants with odds ratios greater than 2.2 (assuming disease allele frequency of 0.5 and disease prevalence of 0.5 in an additive model, calculated by CaTS [57]) with a genome-wide significance level ( P - value less than 5 × 10 − 8 ).”
InfluentialThe Genetic Landscape of Renal Complications in Type 1 Diabetes
Sandholm, N., Van Zuydam, N., Ahlqvist, E., Juliusdottir, T., Deshmukh, H. A., Rayner, N. W., Di Camillo, B., Forsblom, C., Fadista, J., Ziemek, D., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020231 · Cited by 129
ARG1 Is a Novel Bronchodilator Response Gene
Litonjua, A. A., Lasky-Su, J. A., Schneiter, K., Tantisira, K. G., Lazarus, R. M., Klanderman, B. J., Lima, J. J., Irvin, C. G., Peters, S. P., Hanrahan, J. P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1363oc · Cited by 137
“For each SNP in which the direction of the association was in the same direction in each of the four populations, we then combined the P values (two-sided) from the original family-based analysis and the one-sided P values from the replication cohorts using Fisher’s method (27) to increase statistical efficiency (28).”
MethodEstimating Effects and Making Predictions from Genome-Wide Marker Data
Goddard, M. E., Wray, N. R., Verbyla, K., & Visscher, P. M. (2009) · Statistical Science · doi:10.1214/09-sts306 · Cited by 119
“In contrast, classical estimates of SNP effects combining the initial GWAS and the validation study (as in [39]) will still be biased for SNPs selected on the basis of the GWAS.”
ResultHigh-resolution copy number variation analysis of schizophrenia in Japan
Kushima, I., Aleksić, B., Nakatochi, M., Shimamura, T., Shiino, T., Yoshimi, A., Kimura, H., Takasaki, Y., Wang, C., Xing, J., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.88 · Cited by 140
Kavousi, M., Bos, M. M., Barnes, H. J., Lino Cardenas, C. L., Wong, D., Lu, H., Hodonsky, C. J., Landsmeer, L. P. L., Turner, A. W., Kho, M., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01518-4 · Cited by 122
DAPK1 variants are associated with Alzheimer's disease and allele-specific expression
Li, Y., Grupe, A., Rowland, C., Nowotny, P., Kauwe, J. S. K., Smemo, S., Hinrichs, A., Tacey, K., Toombs, T. A., Kwok, S., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl178 · Cited by 125
“Overall, the disease association for a complex disease is generally evaluated through a meta-analysis of all tested sample sets, which also provides greater power than the analysis of multiple smaller sample sets (19,20).”
BackgroundA genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study
Murabito, J. M., Rosenberg, C. L., Finger, D., Kreger, B. E., Levy, D. A., Splansky, G. L., Antman, K. H., & Hwang, S. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s6 · Cited by 132
“A two-stage approach, genome-wide association followed by selective genotyping of SNPs with suggestive evidence of association, may provide an efficient strategy for pursuing initial genome-wide results [2,38,39].”
MethodWild, P. S., Felix, J. F., Schillert, A., Teumer, A., Chen, M.-H., Leening, M. J. G., Völker, U., Großmann, V., Brody, J. A., Irvin, M. R., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci84840 · Cited by 129
“In the GWAS, P 5 × 10 –8 for the combined stage 1 and 2 analysis was deemed significant (11), which corresponds to a significance level of 0.05 after correcting for 1 million independent SNPs (51).”
InfluentialOptimal designs for two‐stage genome‐wide association studies
Skol, A. D., Scott, L. J., Abecasis, G. R., & Boehnke, M. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20240 · Cited by 130
“At the end of stage 2, the overall evidence for association is evaluated by combining the statistics from the two stages [Skol et al., 2006].”
MethodSelf-citationCOGENT-Kidney Consortium, Bentley, A. R., EPIC-InterAct Consortium, Understanding Society Scientific Group, Cohort, L., Sung, Y. J., Brown, M. R., Winkler, T. W., Kraja, A. T., Ntalla, I., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0378-y · Cited by 123
Chen, G.-B., Lee, S. H., Brion, M.-J. A., Montgomery, G. W., Wray, N. R., Radford-Smith, G. L., Visscher, P. M., & the International IBD Genetics Consortium (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu174 · Cited by 121
Ma, X., Zhang, B., & Zheng, W. (2013) · Gut · doi:10.1136/gutjnl-2012-304121 · Cited by 140
Thabet, K., Asimakopoulos, A., Shojaei, M., Romero-Gomez, M., Mangia, A., Irving, W. L., Berg, T., Dore, G. J., Grønbæk, H., Sheridan, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12757 · Cited by 130
UK Testicular Cancer Collaboration, Litchfield, K., The PRACTICAL Consortium, Levy, M., Orlando, G., Loveday, C., Law, P. J., Migliorini, G., Holroyd, A., Broderick, P., et al. (2017) · Nature Genetics · doi:10.1038/ng.3896 · Cited by 127
Interethnic analyses of blood pressure loci in populations of East Asian and European descent
Takeuchi, F., Akiyama, M., Matoba, N., Katsuya, T., Nakatochi, M., Tabara, Y., Narita, A., Saw, W.-Y., Moon, S., Spracklen, C. N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07345-0 · Cited by 122
Wang, L., Hauser, E. R., Shah, S. H., Pericak‐Vance, M. A., Haynes, C. S., Crosslin, D. R., Harris, M., Nelson, S. C., Hale, A. B., Granger, C. B., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/512981 · Cited by 127
Galamb, O., Györffy, B., Sipos, F., Spisák, S., Németh, A. M., Miheller, P., Tulassay, Z., Dinya, E., & Molnár, B. (2008) · Disease Markers · doi:10.1155/2008/586721 · Cited by 120
“As recently described, joint analysis is more efficient than replication based analysis for two-stage genome-wide association studies [33].”
MethodScreen and clean: a tool for identifying interactions in genome‐wide association studies
Wu, J., Devlin, B., Ringquist, S., Trucco, M., & Roeder, K. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20459 · Cited by 126
“This approach lies somewhere between classical replication analysis and joint analysis of the data [Skol et al., 2006].”
Palmer, C., & Pe’er, I. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006916 · Cited by 121
Confirmation of Multiple Crohn's Disease Susceptibility Loci in a Large Dutch–Belgian Cohort
Weersma, R. K., Stokkers, P. C. F., Cleynen, I., Wolfkamp, S. C., Henckaerts, L., Schreiber, S., Dijkstra, G. D. H., Franke, A., Nolte, I. M., Rutgeerts, P. J., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.112 · Cited by 130
Willer, C. J., Bonnycastle, L. L., Conneely, K. N., Duren, W. L., Jackson, A., Scott, L. J., Narisu, N., Chines, P. S., Skol, A. D., Stringham, H. M., et al. (2006) · Diabetes · doi:10.2337/db06-0461 · Cited by 123
“We determined the power of our two-stage study using the power calculator CaTS (11) (available at http://www.”
MethodInfluentialSelf-citationGenomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci
Weissglas-Volkov, D., Aguilar-Salinas, C. A., Nikkola, E., Deere, K. A., Cruz-Bautista, I., Arellano-Campos, O., Muñoz-Hernandez, L. L., Gomez-Munguia, L., Ordoñez-Sánchez, M. L., Reddy, P. M. V. L., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101461 · Cited by 118
Zhao, J. H. (2007) · Journal of Statistical Software · doi:10.18637/jss.v023.i08 · Cited by 116
“The method by Skol et al. (2006) for two-stage design has been implemented in function tscc .”
MethodInfluentialDESGESCO (Dementia Genetics Spanish Consortium), E. (. D. E. D. B., van der Lee, S. J., biobank), E. (. D. E. D., IFGC (International FTD-Genomics Consortium), I. (. I. P. D. G. C., IPDGC (The International Parkinson Disease Genomics Consortium), Dementia), R.-F. (. A. M. F. I. F.-T., (NBB), N. B. B., The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Conway, O. J., Jansen, I., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02026-8 · Cited by 120
Docherty, S. J., Davis, O. S. P., Kovas, Y. V., Meaburn, E. L., Dale, P. S., Petrill, S. A., Schalkwyk, L. C., & Plomin, R. J. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00553.x · Cited by 127
“Although the addition of the second scanning stage improved the SNPselection process, and ensured co-twins were in different samples, performing a joint analysis of samples 1 and 2 would have increased power (Skol et al. 2006).”
Stevenson, A., Akena, D. H., Stroud, R. E., Atwoli, L., Campbell, M., Chibnik, L. B., Kwobah, E., Kariuki, S. M., Martin, A. R., de Menil, V. P., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025469 · Cited by 123
“15 or greater.(24) For more common variants with MAF=25%, we have 89% power to a see significant OR as low as 1.”
BackgroundA two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis
Chiò, A., Schymick, J. C., Restagno, G., Scholz, S. W., Lombardo, F., Lai, S.-L., Mora, G., Fung, H., Britton, A. F., Arepalli, S., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp059 · Cited by 124
Loomis, S. J., Kang, J. H., Weinreb, R. N., Yaspan, B. L., Bailey, J. N. C., Gaasterland, D., Gaasterland, T., Lee, R. K., Lichter, P. R., Budenz, D. L., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.012 · Cited by 116
Nielsen, J. B., Fritsche, L. G., Zhou, W., Teslovich, T. M., Holmen, O. L., Gustafsson, S., Gabrielsen, M. E., Schmidt, E. M., Beaumont, R., Wolford, B. N., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.12.003 · Cited by 114
“formed on the basis of observed allele frequencies and the numbers of case and control individuals as described previously.(33)”
MethodSelf-citationJanicki, P. K., Vealey, R., Liu, J., Escajeda, J., Postula, M., & Welker, K. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31821810c7 · Cited by 117
“Thus, the calculations of the approximate power statistics and sample size were performed based on the method described by Skol et al. (2006) and using their CaTS—Power Calculator for Two Stage Association Studies.27** Based on the population incidence of PONV (35%), we calculated that the power to…”
MethodMultiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions
de Vries, P. S., Brown, M. R., Bentley, A. R., Sung, Y. J., Winkler, T. W., Ntalla, I., Schwander, K., Kraja, A. T., Guo, X., Franceschini, N., et al. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz005 · Cited by 115
Genome-Wide Significance Levels and Weighted Hypothesis Testing
Roeder, K., & Wasserman, L. (2009) · Statistical Science · doi:10.1214/09-sts289 · Cited by 107
“These results are corroborated by Skol et al. (2006) in a related context.”
ResultGene‐Environment Interactions in Cancer Epidemiology: A National Cancer Institute Think Tank Report
Hutter, C. M., Mechanic, L. E., Chatterjee, N., Kraft, P. L., & Gillanders, E. M. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21756 · Cited by 120
Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network
The electronic Medical Records and Genomics (eMERGE) Network, Crosslin, D. R., McDavid, A., Weston, N., Nelson, S. C., Zheng, X., Hart, E., de Andrade, M., Kullo, I. J., McCarty, C. A., et al. (2012) · Human Genetics · doi:10.1007/s00439-011-1103-9 · Cited by 108
“In general, it is more advantageous to perform a joint analysis over a replication-based analysis (Skol et al. 2006).”
Liu, Y., Liu, Z., Song, Y., Zhou, D., Zhang, D., Zhao, T., Chen, Z., Yu, L., Yang, Y., Feng, G., et al. (2010) · Obesity · doi:10.1038/oby.2009.469 · Cited by 122
Krohn, L., Heilbron, K., Blauwendraat, C., Reynolds, R. H., Yu, E., Senkevich, K. A., Rudakou, U., Estiar, M. A., Gustavsson, E. K., Brolin, K. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34732-5 · Cited by 115
Metadata
- Authors
- Skol, A. D., Scott, L. J., Abecasis, G. R., & Boehnke, M.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Boehnke, Michael
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 2
- Pages
- 209-213
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2140126911
- Cited by
- 1,286
- References
- 21
- Citations by year
- 2026: 7 · 2025: 32 · 2024: 35 · 2023: 32 · 2022: 36 · 2021: 45 · 2020: 47 · 2019: 56 · 2018: 55 · 2017: 76 · 2016: 65 · 2015: 52 · 2014: 70 · 2013: 69 · 2012: 95
- FWCI
- 61.77
- Type
- journal article
- Language
- en
- Update notices
- erratum (2006-03-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Forensic and Genetic Research
- Keywords
- joint analysis, statistical power, sample allocation, marker selection, effect size heterogeneity, significance level
- MeSH terms
- Alleles, DNA Replication, Gene Frequency, Genetic Markers, Genetics, Medical, Genotype, Humans, Genome, Human, Case-Control Studies, Genetic Heterogeneity, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.